

Awarded Grants
2022 Grants
2022 Grants and Awards
Organization: American Heart Association
Description: A grant to support Cardiovascular Disease Research
Amount: $100,000
Location of Grantee: San Antonio, Texas
Organization: Boysville, Inc.
Description: A grant to support Boysville, Inc.
Amount: $180,000
Location of Grantee: San Antonio, Texas
Organization: Children’s Hospital of San Antonio
Description: A grant to support of the Pediatric Neurosurgery Epilepsy Program
Amount: $666,666 in 2022 and $2,000,000 over 3 Years
Location of Grantee: San Antonio, Texas
Organization: Foundation Fighting Blindness
Description: A grant to support Age Related Macular Degeneration Research
Amount: $175,000
Location of Grantee: Columbia, Maryland
Organization: I Care San Antonio
Description: A grant to support Patient Vision Services at Haven for Hope
Amount: $75,000
Location of Grantee: San Antonio, Texas
Organization: Muscular Dystrophy Association
Description: A grant to support the MDA Care Center Network
Amount: $100,000
Location of Grantee: San Antonio, Texas
Organization: UT Health San Antonio
Description: A grant to fund the Voelcker Biomedical Research Academy
Amount: $203,318
Location of Grantee: San Antonio, Texas
Organization: University of Texas, San Antonio
Description: A grant to support the Max and Minnie Tomerlin Voelcker Center for Innovative Drug Discovery Preclinical Pharmacology Core for Accelerated Drug Discovery
Amount: $347,000 in 2022 and $883,000 over 3 Years
Location of Grantee: San Antonio, Texas
2022 Voelcker Fund Young Investigator Awards:
Dr. Crystal Archer, Ph.D.
University of Texas Health, San Antonio, Texas
Mechanism of Ankyrin G Regulation of the Epithelial Na+ Channel
Dr. Masahiro Morita, Ph.D.
University of Texas Health, San Antonio, Texas
mRNA Translation and Mitochondrial Dynamics in Obesity-induced Liver Cancer
Dr. Neelam Mukherjee, Ph.D.
University of Texas Health, San Antonio, Texas
Effect of Nitration on CCL2 Mediated Bladder Tumor
Dr. Angelina Vaseva, M.D.
University of Texas Health, San Antonio, Texas
Utilizing Type 2 RAF inhibitors for the Treatment of NF1-associated MPNST

Previous Grants
​​

